ArticleCell death and differentiation2026

KRAS/ERK2-driven stabilization of AARS1 reprograms tumor metabolism and confers Sorafenib resistance in lung adenocarcinoma.

Wenxuan Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.